NASDAQ:FTSMFirst Trust Enhanced Short Maturity ETF Stock Price, Forecast & News

First Trust Enhanced Short Maturity ETF's stock was trading at $60.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, FTSM stock has increased by 0.0% and is now trading at $60.08.
View which stocks have been most impacted by COVID-19.

First Trust Enhanced Short Maturity ETF declared a monthly dividend on Monday, June 29th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.056 per share on Monday, July 6th. This represents a $0.67 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date is Tuesday, June 30th.
View First Trust Enhanced Short Maturity ETF's dividend history.

News coverage about FTSM stock has been trending somewhat negative recently, according to InfoTrie. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. First Trust Enhanced Short Maturity ETF earned a coverage optimism score of -1.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about First Trust Enhanced Short Maturity ETF.

First Trust Enhanced Short Maturity ETF saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 159,700 shares, an increase of 38.3% from the June 15th total of 115,500 shares. Based on an average daily volume of 933,100 shares, the short-interest ratio is currently 0.2 days.
View First Trust Enhanced Short Maturity ETF's Short Interest.

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Enhanced Short Maturity ETF investors own include Cigna (CI), First American Financial (FAF), Stellar Biotechnologies (SBOT), Abraxas Petroleum (AXAS), Anavex Life Sciences (AVXL), AngloGold Ashanti (AU), Asure Software (ASUR), argenx (ARGX), Digital Turbine (APPS) and Air Products & Chemicals (APD).

First Trust Enhanced Short Maturity ETF trades on the NASDAQ under the ticker symbol "FTSM."

First Trust Enhanced Short Maturity ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include UBS Group AG (3.80%), CWM LLC (2.57%), Raymond James Financial Services Advisors Inc. (2.04%), Raymond James & Associates (1.62%), Synovus Financial Corp (0.83%) and HighTower Advisors LLC (0.72%).

FTSM stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, CWM LLC, Synovus Financial Corp, Raymond James Financial Services Advisors Inc., Sawtooth Solutions LLC, AE Wealth Management LLC, Milestone Advisory Partners, and Barber Financial Group Inc..

FTSM stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG, StoneX Group Inc., G&S Capital LLC, Lubar & Co. Inc, LexAurum Advisors LLC, Wedbush Securities Inc., Raymond James & Associates, and HighTower Advisors LLC.

Shares of FTSM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of FTSM stock can currently be purchased for approximately $60.08.

First Trust Enhanced Short Maturity ETF has a market capitalization of $5.09 billion.